Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.56% | 183.80 | 1.3% | $480.23m | |
| ARRY | Array BioPharma Inc. | 0.05% | 46.53 | 8.1% | $426.77m | |
| CELG | Celgene Corporation | 0.35% | 98.17 | 1.3% | $407.46m | |
| GILD | Gilead Sciences, Inc. | 0.41% | 68.54 | 0.9% | $395.13m | |
| BIIB | Biogen Inc. | 0.45% | 234.95 | 1.3% | $352.27m | |
| ILMN | Illumina, Inc. | 1.41% | 356.91 | 3.5% | $286.20m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.22% | 320.83 | 2.6% | $240.90m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.61% | 182.86 | 1.9% | $218.03m | |
| A | Agilent Technologies, Inc. | 0.22% | 72.81 | 1.6% | $195.66m | |
| EXAS | Exact Sciences Corporation | -0.83% | 115.03 | 24.1% | $187.59m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.43% | 128.02 | 2.0% | $184.09m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.35% | 86.17 | 4.3% | $129.56m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.84% | 130.59 | 14.7% | $109.18m | |
| INCY | Incyte Corporation | 2.03% | 86.59 | 2.5% | $108.60m | |
| MRTX | Mirati Therapeutics Inc. | 3.10% | 104.37 | 2.5% | $101.45m |
Company Profile
Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.